HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of oropharyngeal decontamination using topical nonabsorbable antibiotics on the incidence of nosocomial respiratory tract infections in multiple trauma patients.

Abstract
The incidence of respiratory tract infections was determined in 59 multiple trauma patients requiring prolonged intensive care (greater than 5 days) and receiving no antibiotic prophylaxis. Early pneumonia (less than 48 hr) with S. aureus, S. pneumoniae, and/or H. influenzae was found in 44% of patients. Secondary colonization of the oropharynx and respiratory tract with ICU-associated Gram-negative bacilli followed by pneumonia occurred in 12 patients (20%). The overall incidence of respiratory tract infections was 59%. In a prospective open trial three prophylactic antibiotic regimens were compared: 17 patients were treated with intestinal decontamination using nonabsorbable antibiotics (polymyxin E 400 mg, tobramycin 320 mg, amphotericin B 2,000 mg/day). No difference in infection rate was found. Twenty-five patients were treated with intestinal and oropharyngeal decontamination using an ointment containing 2% of the same antibiotics. Secondary colonization and infection of the respiratory tract with Gram-negative bacilli was significantly reduced (p less than 0.001). The incidence of early (Gram-positive) infections, however, was unchanged. Another group of 63 patients was treated with systemic antibiotic prophylaxis during the first days in combination with oropharyngeal and intestinal decontamination. The incidence of early pneumonia was significantly reduced (p less than 0.001). Five patients (8%) developed an infection. Superinfections were not observed.
AuthorsC P Stoutenbeek, H K van Saene, D R Miranda, D F Zandstra, D Langrehr
JournalThe Journal of trauma (J Trauma) Vol. 27 Issue 4 Pg. 357-64 (Apr 1987) ISSN: 0022-5282 [Print] United States
PMID3033259 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Polymyxins
  • Amphotericin B
  • Tobramycin
Topics
  • Administration, Topical
  • Adolescent
  • Adult
  • Amphotericin B (administration & dosage)
  • Anti-Bacterial Agents (pharmacology)
  • Bacteria (drug effects)
  • Bacterial Infections (epidemiology, prevention & control)
  • Cross Infection (epidemiology, prevention & control)
  • Decontamination (methods)
  • Female
  • Humans
  • Intestines (microbiology)
  • Male
  • Middle Aged
  • Oropharynx (microbiology)
  • Pneumonia (epidemiology, etiology)
  • Pneumonia, Staphylococcal (epidemiology, etiology)
  • Polymyxins (administration & dosage)
  • Prospective Studies
  • Respiratory System (microbiology)
  • Respiratory Tract Infections (epidemiology, prevention & control)
  • Retrospective Studies
  • Tobramycin (administration & dosage)
  • Wounds and Injuries (complications, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: